Archived documents
Documents past their public comment period for FDA.
FDA ▾
Food Additive Petition seeking amended food additive regulations to remove FDA's approval of four carcinogenic solvents
14 comments
Net support -14% across analyzed comments
Top issues in comments
- Removal of carcinogenic food additives
FDA Review of Select Ortho-Phthalate Food Contact Substances as Chemically or Pharmacologically Related (CPR) Substances
13 comments · 9 awaiting analysis
Net support +100% across analyzed comments
Top issues in comments
Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Prescription Drug User Fee Act Products; Draft Guidance for Industry
13 comments · 8 awaiting analysis
Net support +40% across analyzed comments
Top issues in comments
Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List Additions and Request for Comments
12 comments · 11 awaiting analysis
Net support 0% across analyzed comments
Top issues in comments
Fiscal Year 2026 Generic Drug Science and Research Initiatives Workshop; Public Workshop; Request for Comments
9 comments · 4 awaiting analysis
Net support +80% across analyzed comments
Top issues in comments
- Independent batch testing
- Nitrosation reaction rate
- Pediatric drug development
Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey
8 comments · 8 awaiting analysis
Analysis in progress
Top issues in comments
Azodicarbonamide (ADA); Request for Information
7 comments · 5 awaiting analysis
Net support +100% across analyzed comments
Top issues in comments
Acute Radiation Syndrome: Developing Drugs for Prevention and Treatment; Guidance for Industry; Draft Guidance
7 comments · 7 awaiting analysis
Analysis in progress
Top issues in comments
Compliance Policy Regarding Premarket and Other Requirements for Certain NIOSH Approved Air-Purifying Respirators; Draft Guidance for Industry and Food and Drug Administration Staff
7 comments
Net support +100% across analyzed comments
Top issues in comments
- Regulatory oversight and clarity
- Clarify intended audience
- Occupational safety and heat stress
Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-inHuman (FIH) Trials; Guidance for Industry; Draft Guidance
6 comments · 5 awaiting analysis
Net support 0% across analyzed comments
Top issues in comments
Challenges and Solutions in Lot-Level Food Traceability; Public Meeting and Request for Comments
6 comments
Net support +67% across analyzed comments
Top issues in comments
- Gs1 standards adoption
- Imprinting requirements on individual packages
- Mobile application for traceability
Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information
4 comments · 3 awaiting analysis
Net support +100% across analyzed comments
Top issues in comments
- Pediatric and neonatal considerations
